Today

Ducommun Inc. declared its past financial statements unreliable due to an accounting error, requiring a restatement and revealing a material weakness in internal controls.

Clear Secure reported strong Q4 and full-year 2025 financial results, with significant growth in revenue and Adjusted EBITDA, alongside increased dividends and an expanded share repurchase program.

Kroger will redeem $4.7 billion in senior notes on December 18, 2024, at 101% of principal, triggered by the termination of its merger agreement with Albertsons.

Cambium Networks announced that its financial statements for fiscal years 2022 and 2023, and several interim periods in 2023 and 2024, can no longer be relied upon and will be restated due to material errors.

Workday is cutting 8.5% of its workforce and expects significant charges, impacting its GAAP operating margin.

Vroom, Inc. has filed for Chapter 11 bankruptcy, triggering the immediate acceleration of $291.3 million in debt.

Danimer Scientific and its subsidiaries have filed for Chapter 11 bankruptcy, leading to the immediate acceleration of approximately $400.8 million in debt.

AST SpaceMobile reported Q1 2026 results, reaffirming full-year revenue guidance and detailing significant progress in satellite deployment and regulatory approvals.

Celsius Holdings reported record first-quarter revenue and strong earnings, driven by recent acquisitions and robust brand performance.

Klarna Group plc reported a strong first quarter, returning to net profitability and showing significant growth across key financial metrics.

Circle Internet Group raised $222 million in a private presale of 740 million ARC tokens, introducing a new digital asset to its blockchain network.

Exzeo Group reported strong first-quarter 2026 financial results with increased revenue, net income, and managed premium.

MongoDB delivered strong fourth quarter and full year fiscal 2026 results, provided optimistic fiscal 2027 guidance, and announced key leadership transitions.

Focus Universal closed $10 million in convertible preferred stock private placements, introducing significant future dilution risk for common shareholders.

Upexi completed a $100 million private placement of common stock and pre-funded warrants, alongside issuing additional warrants to an asset manager, significantly increasing potential share dilution.

TransCode Therapeutics shareholders approved the issuance of common stock upon warrant exercise, including price adjustments and a cashless exercise feature, which could lead to significant future dilution.

Lyra Therapeutics' stockholders approved a reverse stock split, which the Board then set at a 1-for-50 ratio, effective May 27, 2025.

Dogwood Therapeutics completed a $12.5 million offering of common stock and warrants, with pre-funded warrants immediately exercisable, while also terminating its ATM program.

OLB Group completed a private placement of pre-funded and common warrants, generating $3.0 million in gross proceeds and creating substantial future share dilution.

Duos Technologies Group is raising approximately $55 million through an offering of common stock and pre-funded warrants, which will significantly increase its share count.